194 related articles for article (PubMed ID: 25056539)
1. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.
Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F
Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539
[TBL] [Abstract][Full Text] [Related]
2. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.
Shin DJ; Osborne TF
J Biol Chem; 2009 Apr; 284(17):11110-20. PubMed ID: 19237543
[TBL] [Abstract][Full Text] [Related]
3. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
Song KH; Li T; Owsley E; Strom S; Chiang JY
Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
[TBL] [Abstract][Full Text] [Related]
4. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
[TBL] [Abstract][Full Text] [Related]
5. Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids.
Yu C; Wang F; Jin C; Huang X; McKeehan WL
J Biol Chem; 2005 May; 280(18):17707-14. PubMed ID: 15750181
[TBL] [Abstract][Full Text] [Related]
6. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15/19 signaling to repress bile acid synthesis.
Li S; Hsu DD; Li B; Luo X; Alderson N; Qiao L; Ma L; Zhu HH; He Z; Suino-Powell K; Ji K; Li J; Shao J; Xu HE; Li T; Feng GS
Cell Metab; 2014 Aug; 20(2):320-32. PubMed ID: 24981838
[TBL] [Abstract][Full Text] [Related]
9. The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.
Li Q; Zhao Q; Zhang C; Zhang P; Hu A; Zhang L; Schroder PM; Ma Y; Guo Z; Zhu X; He X
J Physiol Biochem; 2018 May; 74(2):247-260. PubMed ID: 29468415
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
[TBL] [Abstract][Full Text] [Related]
12. Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4.
Gutierrez A; Ratliff EP; Andres AM; Huang X; McKeehan WL; Davis RA
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):301-6. PubMed ID: 16284190
[TBL] [Abstract][Full Text] [Related]
13. Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway.
Kouno T; Liu X; Zhao H; Kisseleva T; Cable EE; Schnabl B
J Biol Chem; 2022 Jul; 298(7):102056. PubMed ID: 35605662
[TBL] [Abstract][Full Text] [Related]
14. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4.
Yu C; Wang F; Kan M; Jin C; Jones RB; Weinstein M; Deng CX; McKeehan WL
J Biol Chem; 2000 May; 275(20):15482-9. PubMed ID: 10809780
[TBL] [Abstract][Full Text] [Related]
15. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways.
Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J
PLoS One; 2011 Mar; 6(3):e17868. PubMed ID: 21437243
[TBL] [Abstract][Full Text] [Related]
16. FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway.
Jung D; York JP; Wang L; Yang C; Zhang A; Francis HL; Webb P; McKeehan WL; Alpini G; Lesage GD; Moore DD; Xia X
Pflugers Arch; 2014 May; 466(5):1011-9. PubMed ID: 24068255
[TBL] [Abstract][Full Text] [Related]
17. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
[TBL] [Abstract][Full Text] [Related]
18. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.
Holt JA; Luo G; Billin AN; Bisi J; McNeill YY; Kozarsky KF; Donahee M; Wang DY; Mansfield TA; Kliewer SA; Goodwin B; Jones SA
Genes Dev; 2003 Jul; 17(13):1581-91. PubMed ID: 12815072
[TBL] [Abstract][Full Text] [Related]
19. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
[TBL] [Abstract][Full Text] [Related]
20. Disrupted Murine Gut-to-Human Liver Signaling Alters Bile Acid Homeostasis in Humanized Mouse Liver Models.
Chow EC; Quach HP; Zhang Y; Wang JZ; Evans DC; Li AP; Silva J; Tirona RG; Lai Y; Pang KS
J Pharmacol Exp Ther; 2017 Jan; 360(1):174-191. PubMed ID: 27789682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
